Fudan University Shanghai Cancer Center

Fudan University Shanghai Cancer Center (FUSCC)—Profile Overview

History & Status

• Founded: March 1, 1931, as the Sino-Belgian Radium Institute—the first dedicated cancer hospital in China.

• Affiliation: A Grade 3, Class A teaching hospital at Shanghai Medical College, Fudan University.

• Campus: Two main sites—Xuhui District (main hospital) and the Shanghai Proton and Heavy Ion Hospital in Pudong.

Size & Capacity

• Beds: Approx. 1,100 licensed; around 2,149 beds in operation as of 2023.

• Staff: Nearly 2,979 employees (2023), including clinical, technical, research, and administrative personnel.

• Patient Volume (2023):

  • ~2 million outpatient visits

  • ~163,800 inpatient admissions

  • ~71,000 surgeries

Core Missions
FUSCC operates at the intersection of

1. Clinical Excellence—high-quality care through multidisciplinary teams.

2. Medical Education—training residents and specialists and hosting academic programs with national-level accreditation.

3. Oncologic Research encompasses everything from basic lab work to large clinical trials, particularly in precision medicine.

4. The field of Cancer Prevention & Public Health involves outreach, screening initiatives, and collaboration with both local and national bodies.

🔬 Research & Innovation

• Publications: Over 300 SCI-indexed papers annually in top-tier journals (e.g., Nature, JCO, JNCI).

• Awards & Projects (2023): 89 new NSFC grants, 12 papers in journals with IF ≥ 20, ~424 clinical studies (292 domestic, 21 international).

• Strategic Focus:

  • Precision oncology and biomarkers

  • Pioneering immunotherapy studies for breast cancer (e.g., HR+/HER2‑ subtype)

  • Proteogenomics and metabolic immunotherapy breakthroughs

Collaborations & Influence

• International Partnerships: Sister-institution ties with MD Anderson (USA), National University Cancer Institute (Singapore), Institut Gustave Roussy (France), Duke, Peter Mac (Australia), Princess Margaret (Canada), and more.

• National Leadership:

  • Authorized by multiple ministries as a key discipline center

  • The center designs clinical and translational research platforms, such as oncology quality control labs and gene therapy centers.

  • The organization has played central roles in national cancer control for regions such as Xizang, Xinjiang, Yunnan, and abroad, such as Morocco.

Impact & Recognition

• Survival Outcomes: 5-year cancer survival rates are ~71.6%, leading nationally and aligning with developed country standards.

• Research Standing:

  • In terms of output share and impact in health sciences and oncology, FUSCC ranks among the top cancer centers in China and globally.

• Palliative Care Pioneer: China’s first dedicated palliative unit established in 2006.

FUSCC is China’s foremost comprehensive cancer institution—bridging patient care, education, research, prevention, and innovation. Its century-long legacy, vast patient base, strong academic output, and strategic global ties position it as a leading force in oncology, both nationally and internationally.

Core Clinical Specialties

FUSCC operates 43–45 clinical and technical departments across its two campuses (Xuhui & Pudong), including the integrated Proton & Heavy Ion Hospital. Major specialties include:

• Breast Surgery & Oncology—A nationally recognized center, led by Dr. Shao Zhimin. The center is responsible for defining subtypes and precision treatment strategies for triple-negative breast cancer.

• Pancreatic Surgery/Pancreatic Tumor Center—Established in 2010, a leading center in China for pancreatic and periampullary tumors. Performs ~2,500 surgeries annually with a high rate of minimally invasive procedures and pioneers the “Fudan approach”.

• Head & Neck Surgery—Expert care for thyroid, laryngeal, pharyngeal, and tongue cancers. Professor Ji Qinghai has over 30 years of clinical and research leadership in this field.

• Thoracic Surgery—Advanced care for lung and esophageal cancers; integrated use of surgery, radiotherapy, and chemo.

• Colorectal Surgery—Multidisciplinary treatment including advanced surgical techniques.

• Gastrointestinal Surgery—Covers stomach, liver, and biliary tract cancers, and more.

• Urology Surgery—Prostate, bladder, kidney, and other urinary malignancies.

• Hepatobiliary Surgery—Leading expertise in liver and bile duct cancers.

• Brain & Spine Surgery—Treatment for cranial and spinal tumors.

• Musculoskeletal Oncology—Focused on bone and soft-tissue sarcomas.

• Gynecologic Oncology encompasses the treatment of ovarian, cervical, and uterine cancers.

Support services include anesthesiology, intensive care (ICU), nutritional medicine, interventional radiology, pathology, molecular diagnostics, medical imaging, nuclear medicine, and more.

Radiation & Precision Oncology

• Radiation Oncology & Proton/Heavy Ion Therapy—State-of-the-art departments offering photon, proton, and heavy-ion therapies. The Pudong-based Proton & Heavy Ion Hospital began operations in May 2015 and treats a broad spectrum of tumors (e.g., head & neck, skull base, prostate).

• The Clinical Radiotherapy Center, recognized by the Ministry of Health as a key national clinical discipline, offers integrated and advanced radiotherapy services.

Integrative & Traditional Chinese Medicine (TCM)

• The Integrative Oncology Department has received national designation as a specialty. The department integrates TCM and Western medicine to enhance symptom control, minimize side effects, and improve patient quality of life.

Medical Oncology & Clinical Trials

• Medical (Internal) Oncology provides comprehensive management of solid tumors through chemotherapy, targeted medication, immunotherapy, and CAR-T trials. FUSCC is among the world’s top hospitals for CAR-T clinical research.

• The Early-Phase/Phase I Trial Center actively participates in novel-agent trials, which include immuno-oncology and molecular-targeted therapies.

Pathology & Molecular Diagnostics

• The institution houses National Key Discipline labs that specialize in pathology, radiation oncology, and breast cancer. The institution manages quality-control centers at the Shanghai level for pathology and radiotherapy, as well as a national drug clinical trial facility.

• The institution boasts robust DNA/proteogenomic platforms that facilitate personalized oncology research and diagnostics.

Specialized Multi-Disciplinary & Support Service Units

• Multidisciplinary Tumor Boards (MDT) are dedicated single-disease centers that facilitate coordinated, tumor-specific care across various disciplines.

• Clinical Nutrition & Palliative Care—This unit pioneered full-spectrum nutrition management and established China’s first palliative care unit in 2006.

• Interventional Oncology—Includes ablation, intra-arterial infusion, hyperthermic perfusion, and radiofrequency for minimally invasive cancer treatments.

• Anesthesiology & Enhanced Recovery After Surgery (ERAS)—Puts a strong emphasis on perioperative care, pain management, and rapid patient recovery protocols.

• Imaging & Nuclear Medicine—Full suite of diagnostic services: PET-CT, PET-MRI, MRI 5.0T, high-end ultrasound, etc.

Summary Table

FUSCC offers a wide range of services for cancer care, including surgery, radiation, medical treatment, TCM integration, interventional therapies, diagnostics, nutrition, rehabilitation, palliative care, and new research, all focused on improving patient results and advancing science.

Fudan University Shanghai Cancer Center (FUSCC) boasts a comprehensive and state-of-the-art infrastructure designed to support advanced cancer care, research, education, and patient services. Here’s a detailed look:

Campus Facilities

Main Xuhui Campus

• The main Xuhui campus houses general clinical services and supporting departments, including surgery, medical and radiation oncology, pathology, imaging, nuclear medicine, interventional radiology, ICU, anesthesiology, endoscopy, and more research.

• Features cutting-edge imaging equipment: PET/CT, SPECT, MRI, high-resolution ultrasound, 5.0T MRI, linear accelerators, Co-60 units, high-end CT simulator, and stereotactic biopsy systems.

Pudong Proton & Heavy Ion Branch

• The Pudong Proton & Heavy Ion Branch, located in the Zhangjiang area adjacent to FUSCC, officially opened its doors in 2019.

• The facility has an 800-bed capacity and is dedicated to providing precise diagnostic and treatment services, which include particle therapy, pathology, and individualized research.

• The facility also houses a 2,000-square-meter experimental animal center, which is dedicated to drug development and translational research.

• The facility is staffed and equipped for proton and carbon-ion therapy, and its planning approval dates back to 2005. It was fully operational with Siemens systems by 2014.

Research & Training Infrastructure

• Fudan Cancer Institute (est. 2012) encompasses over 6,000 m² of lab space, 11 research groups, and core facilities in molecular biology, proteomics, tumor microenvironment, and translational platforms like tissue banks and animal imaging.

• The institute houses quality-control centers for pathology, radiotherapy, chemotherapy, and pharmaceutical trials, which are often designated nationally.

Clinical Technical Support

• The facility has implemented comprehensive molecular diagnostics, such as genetic profiling, immunohistochemistry, FISH, and proteogenomic analyses, which are crucial for precision oncology.

• Laboratory infrastructure includes clinical labs, pharmacy units, biochemistry, microbiology, and nuclear medicine.

Patient-Centered & Supportive Facilities

• The campus offers a comprehensive range of supportive services, including an ICU, anesthesiology, a nutrition department, interventional radiology, TCM-Western medicine integration, palliative care (which includes China’s first cancer palliative unit since 2006), and enhanced recovery after surgery programs.

• The experimental animal center in Pudong enables in vivo testing for personalized and novel drug therapies.

Connectivity & Access

• The campus is strategicallylocated near Shanghai Metro access points, with the Pudong campus in Zhangjiang Science Park and Xuhui integrated with city transport networks.

• Proximity to Shanghai Metro expansions enhances accessibility for commuting patients and collaboration.

Summary Table

FUSCC’s infrastructure is built for integrated excellence—combining top-tier clinical care, cutting-edge research, and patient-centric support. It includes high-tech treatment facilities, precision diagnostics, molecular labs, specialized therapy centers, and ambitious translational science platforms. This ensures the hospital stays at the forefront of global oncology.

📍 Location
The Fudan University Shanghai Cancer Center (FUSCC) is located at 270 Dong’an Road, Xuhui District, Shanghai 200032, China.

What is the best way to reach Fudan University Shanghai Cancer Center?

By Metro

• Nearest Station: Dong’an Road Station, served by Lines 4 and 7. Exit the station and walk a few minutes to the hospital.

• Alternative: For those heading to Fudan’s main university campus (Xuhui area), you can also use Line 18 to Fudan University Station, then take a short bus/taxi ride (the medical center is several kilometers southwest).

By Taxi

• From Hongqiao Airport (~18 km): ~ ¥60 (~USD 8), ~30 minutes

• From Pudong Airport (~44 km): ~ ¥170 (~USD 23), ~50–60 minutes

• From Shanghai Railway Station: ~ ¥30, ~15–20 minutes via Line 4 or taxi

Show the driver this address:

“东安路270号 复旦大学附属肿瘤医院”

From Airports via Metro

From Pudong Airport:

1. Take Line 2 toward the city center.

2. Transfer to Line 4 at Century Avenue.

3. Disembark at Dong’an Road Station and walk to the hospital.

From Hongqiao Airport:

1. Take Line 2.

2. Switch to Line 4 at the Zhongshan Park station.

3. Exit at Dong’an Road Station.

From Major Train Stations

• From Shanghai Railway Station:

  • Take Line 4 directly to Dong’an Road (no transfer needed), then walk a short distance to FUSCC.

By Bus or Metro + Bus

Local buses also serve Dong’an Road—check routes on Shanghai Bus & Metro. Alternatively, combine the metro with a short bus ride if you’d prefer that over walking.

💡 Tips:

• Peak traffic occurs during morning/evening rush hours, so the metro may be faster than taxis.

• Taxis and ride-hailing apps (e.g., Didi) are widely available; show the address in Chinese for convenience.

• Airport metro lines operate roughly 06:00–23:00.

270 Dong’an Road, Xuhui District, Shanghai 200032, China

Here’s a detailed overview of the facilities at Fudan University Shanghai Cancer Center (FUSCC):

Clinical & Diagnostic Facilities

• 43 clinical and technical departments, spanning surgical specialties (e.g. breast, pancreatic, thoracic, brain & spine), medical oncology, radiation oncology, TCM-Western integrative oncology, anesthesiology, ICU, interventional radiology, nuclear medicine, diagnostic imaging, endoscopy, ultrasound, pathology, pharmacy, clinical laboratories, and nutrition.

• High-end imaging suite: includes PET–CT and SPECT, 5.0 T MRI, high-resolution CT simulators, and stereo­tactic biopsy systems.

• Radiotherapy center: photon, advanced radiotherapy tech, plus particle beam treatment at the Pudong branch.

Particle Therapy & Pudong Campus

• Shanghai Proton & Heavy Ion Hospital in Pudong:

  • ~800 beds with comprehensive clinical services.

  • Equipped for proton and carbon-ion therapy using Siemens particle accelerators.

  • The facility facilitates translational research through a 2,000-square-meter animal center.

Research & Laboratory Infrastructure

• Fudan Cancer Institute (est. 2012):

  • Over 6,000 m² of lab space with 11 specialized research groups (e.g. immunology, genomics, proteomics).

  • Core facilities: molecular biology, biochemistry, tissue bank, animal imaging, clinical nutrition platform.

• Quality control & trial centers:

  • National/state labs for pathology, radiotherapy, and chemotherapy.

  • Includes a national-level drug clinical trial agency.

Molecular Diagnostics & Pathology

• Complete molecular diagnostics: genetic profiling, immunohistochemistry (IHC), FISH, and proteogenomics.

• The facility facilitates precision oncology by offering biomarker testing, genomic sequencing, and research-enabled diagnostic services.

Supportive & Integrated Services

• First palliative care unit among Chinese cancer centers (since 2006) focusing on patient comfort and symptom management.

• Specialized services: ICU, anesthesia, clinical nutrition, integrative TCM–Western treatment, interventional oncology (ablation, intra-arterial therapy), and ERAS.

• Full-spectrum diagnostic departments: pharmacy, microbiology, biochemistry, nuclear medicine, and cardio-pulmonary function lab.

Summary Table

In summary, FUSCC boasts a world-class infrastructure that seamlessly integrates patient care, high-end diagnostics, translational research, and supportive services. Its dual campuses accommodate cutting-edge technologies—from particle therapy to molecular diagnostics—backed by robust lab and trial ecosystems.